-
www.ahrq.gov/healthsystemsresearch/hspc-research-study/research-gaps.html
June 01, 2020 - 6. Research Gaps and Prioritization of Federally Funded HSR and PCR
Health Services and Primary Care Research Study: Comprehensive Report
One of the study’s key research questions focuses on identifying research gaps—understudied or underfunded areas in HSR and PCR that, if addressed, would move the fields fo…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/nicu_toolkit/nicupacket-apb.pdf
December 10, 2013 - Transitioning Newborns from NICU to Home: Family Information Packet, Appendix B
Appendix B: Clinical Materials to Share
With Primary Care Providers
Diagnoses and Conditions
■ Anemia of Prematurity
■ Apnea of Prematurity
■ Bronchopulmonary Dysplasia
■ Gastroesophageal Reflux
■ Nephrocalcinosis
■ Patent D…
-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2022-Compendium-TechDoc.pdf
January 01, 2022 - In addition, IQVIA uses Drug Distribution Data that enable quick identification of new
organizations … ’s National Plan and Provider
Enumeration System (NPPES), State Controlled Substance Registration, Drug
-
www.ahrq.gov/sites/default/files/publications/files/toolkit.pdf
September 01, 2005 - • Call center—regional poison center, drug line for national companies, nurse advice
line, translation
-
www.ahrq.gov/sites/default/files/publications/files/resphys-champions_2.pdf
September 01, 2015 - use, thus resulting in more antimicrobial resistance, Clostridium difficile
infection, and adverse drug
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/quickref/tobaqrg.pdf
April 01, 2009 - , MPH, CHES, National Heart, Lung, and Blood Institute
Stephen Heishman, PhD, National Institute on Drug
-
www.ahrq.gov/sites/default/files/publications/files/implementation-guide_0.pdf
September 01, 2015 - asymptomatic bacteriuria can lead to antimicrobial resistance, Clostridium difficile infection,
and adverse drug
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/guides/resphys-champions.pdf
September 01, 2015 - use, thus resulting in more antimicrobial resistance, Clostridium difficile
infection, and adverse drug
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/impl-guide/implementation-guide.pdf
September 01, 2015 - asymptomatic bacteriuria can lead to antimicrobial resistance, Clostridium difficile infection,
and adverse drug
-
www.ahrq.gov/sites/default/files/publications/files/resphys-champions.pdf
September 01, 2015 - use, thus resulting in more antimicrobial resistance, Clostridium difficile
infection, and adverse drug
-
www.ahrq.gov/sites/default/files/2024-12/dalton-report.pdf
January 01, 2024 - Under these conditions, safe treatment
options include expectant management and drug therapy to cause
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0085episiotomycoding.xls
January 01, 2012 - FFS
PHDSC 2.16.840.1.113883.221.5 Payer Individual Characteristic Source of Payment Typology 4.0 122 Drug
-
www.ahrq.gov/sites/default/files/wysiwyg/CHIPRA-BMI-Coding.xls
January 01, 2012 - FFS
PHDSC 2.16.840.1.113883.221.5 Payer Individual Characteristic Source of Payment Typology 4.0 122 Drug
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/clabsi-cauti-icu/playbook.pdf
April 01, 2022 - A Playbook for Preventing CLABSI and CAUTI in the ICU Setting
AHRQ Safety Program for Intensive Care
Units: Preventing CLABSI and CAUTI
A Playbook for Preventing
CLABSI and CAUTI in the
ICU Setting
2 Playbook
AHRQ Safety Program for Intensi…
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/clabsi-cauti-icu/playbook_revised.pdf
April 01, 2022 - A Playbook for Preventing CLABSI and CAUTI in the ICU Setting
AHRQ Safety Program for Intensive Care
Units: Preventing CLABSI and CAUTI
A Playbook for Preventing
CLABSI and CAUTI in the
ICU Setting
2 Playbook
AHRQ Safety Program for Intensi…
-
www.ahrq.gov/sites/default/files/wysiwyg/2021-Compendium-TechDoc.pdf
January 01, 2021 - In addition, IQVIA uses Drug Distribution Data that enable
quick identification of new organizations … CMS’ National Plan and Provider
Enumeration System [NPPES], State Controlled Substance Registration, Drug
-
www.ahrq.gov/sites/default/files/wysiwyg/2020-Compendium-TechDoc.pdf
January 01, 2020 - In addition, IQVIA uses Drug Distribution Data that enable quick identification of new
organizations … CMS’ National Plan and Provider
Enumeration System [NPPES], State Controlled Substance Registration, Drug
-
www.ahrq.gov/sites/default/files/publications/files/11-0060-EF.pdf
May 01, 2011 - organizations should include
State and Federal regulatory and financing organizations (e.g., the Food and Drug … organizations
should include State and Federal regulatory and financing organizations (e.g., the Food and Drug
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/consumer-experience/reporting/11-0060-EF.pdf
May 01, 2011 - organizations should include
State and Federal regulatory and financing organizations (e.g., the Food and Drug … organizations
should include State and Federal regulatory and financing organizations (e.g., the Food and Drug
-
www.ahrq.gov/sites/default/files/wysiwyg/workingforquality/2016-cms-agency-specific-plan.pdf
January 01, 2016 - 2016 CMS Quality Strategy
CMS Quality Strategy
2016
Table of Contents
Overview ...................................................................................................................................................... 1
Introduction ............................................…